Steatotic liver disease is the overarching term for conditions characterised by abnormal lipid
accumulation in the liver (liver or hepatic steatosis). Steatotic liver disease encompasses …

Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide, primarily develo** in the context of chronic liver disease …

Background Statins have multiple benefits in patients with metabolic-associated steatotic
liver disease (MASLD). Aim To explore the effects of statins on the long-term risk of all-cause …

Introduction: This study aimed to investigate the liver-related outcomes of newly suggested
metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with …

Abstract Background and Aims The increasing incidence of metabolic dysfunction-
associated steatotic liver disease (MASLD) has led to a gradual increase in MASLD-related …

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a public
health threat as it affects approximately 38% of the adult population worldwide, with its …

Liver cancer is the third leading cause of cancer-related deaths globally, with incident cases
expected to rise from 905,700 in 2020 to 1.4 million by 2040. Hepatocellular carcinoma …

Background Hepatocellular carcinoma (HCC) recurrence following surgical resection
remains a significant clinical challenge, necessitating reliable predictive models to guide …

Statins, the first‐line medication for dyslipidemia, are linked to an increased risk of type 2
diabetes. But exactly how statins cause diabetes is yet unknown. In this study, a developed …

Importance Hepatocellular carcinoma (HCC) and its mortality are on the rise. Viral hepatitis
and alcohol are leading risk factors; however, other risk factors among veterans are less …